Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

The present phase II trial was undertaken to assess the efficacy and toxicity of a combination of paclitaxel and carboplatin as first-line chemotherapy in patients with metastatic transitional cell carcinoma of the urothelium. Twenty patients (age range 50-79 years; inclusion criteria: WHO performan...

Descripción completa

Detalles Bibliográficos
Autores principales: Zielinski, C. C., Schnack, B., Grbovic, M., Brodowicz, T., Wiltschke, C., Steger, G., Pflüger, H., Marberger, M.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063028/
https://www.ncbi.nlm.nih.gov/pubmed/9703285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063028/
https://www.ncbi.nlm.nih.gov/pubmed/9703285

Ejemplares similares